The goal of comparative effectiveness research is to inform clinical decisions between alternate treatment strategies using data that reflect real patient populations and real-world clinical scenarios ...
MK-2206 and Standard Neoadjuvant Chemotherapy Improves Response in Patients With Human Epidermal Growth Factor Receptor 2–Positive and/or Hormone Receptor–Negative Breast Cancers in the I-SPY 2 Trial ...
Policymaking sits at the intersection of political intention, institutional structure, and design practice. In recent years, “design for policy” approaches ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results